01/08/2025 5:39 PM | Kalir Erez (Reporting) Vor Biopharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/08/2025 5:41 PM | Kalir Erez (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2025 8:06 AM | Vor Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/07/2025 3:53 PM | Reprogrammed Interchange LLC (Filed by) Vor Biopharma (Subject)
| Form SCHEDULE 13D | |
01/02/2025 6:37 PM | Hoffman Reid (Reporting) Reprogrammed Interchange LLC (Reporting) Vor Biopharma (Issuer) Vor Biopharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2025 6:42 PM | Hoffman Reid (Reporting) Reprogrammed Interchange LLC (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/31/2024 3:15 PM | Attar Eyal C. (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/30/2024 5:51 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by) Vor Biopharma (Subject)
| Form SCHEDULE 13D/A | |
12/30/2024 5:52 PM | Kolchinsky Peter (Reporting) RA Capital Healthcare Fund LP (Reporting) RA CAPITAL MANAGEMENT, L.P. (Reporting) RA Capital Nexus Fund, L.P. (Reporting) Shah Rajeev M. (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2024 3:17 PM | Attar Eyal C. (Reporting) Vor Biopharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2024 8:05 AM | Vor Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
12/09/2024 6:39 AM | Vor Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 3:33 PM | Paradigm Biocapital Advisors LP (Filed by) Vor Biopharma (Subject)
| Form SC 13G/A | |
11/08/2024 3:15 PM | ANG ROBERT (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2024 3:15 PM | Attar Eyal C. (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2024 3:15 PM | Quinlan Amy (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2024 3:20 PM | Chakraborty Tirtha (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/05/2024 3:15 PM | ANG ROBERT (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/05/2024 3:15 PM | Attar Eyal C. (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/05/2024 3:15 PM | Chakraborty Tirtha (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/05/2024 3:15 PM | Quinlan Amy (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2024 3:16 PM | Choi Han Wook (Reporting) Vor Biopharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
10/02/2024 3:17 PM | Choi Han Wook (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/30/2024 6:05 AM | Vor Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2024 3:06 PM | Vor Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/30/2024 3:01 PM | Vor Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2024 3:29 PM | Chakraborty Tirtha (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2024 3:30 PM | ANG ROBERT (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2024 4:04 PM | Jorgensen Nathan D. (Reporting) Vor Biopharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2024 4:22 PM | Quinlan Amy (Reporting) Vor Biopharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
06/04/2024 5:09 PM | Attar Eyal C. (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 3:38 PM | Attar Eyal C. (Reporting) Vor Biopharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024 3:54 PM | Vor Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/28/2024 3:10 PM | Lundberg Sven Ante (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:10 PM | Kolchinsky Peter (Reporting) RA Capital Healthcare Fund LP (Reporting) RA CAPITAL MANAGEMENT, L.P. (Reporting) RA Capital Nexus Fund, L.P. (Reporting) Shah Rajeev M. (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:10 PM | Patterson Matthew R (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:10 PM | Namouni Fouad (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 3:40 PM | Namouni Fouad (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 3:39 PM | Namouni Fouad (Reporting) Vor Biopharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/09/2024 3:05 PM | Vor Biopharma (Filer)
| Form DEF 14A | |
04/09/2024 3:07 PM | Vor Biopharma (Filer)
| Form DEFA14A | |
Trump’s Sending THIS Crypto Higher on Purpose (Ad) Discover the coin set to explode in 2025!
Trump could trigger THIS crypto coin…
YES, I WANT THE #1 CRYPTO NOW |
04/09/2024 3:10 PM | Vor Biopharma (Filer)
| Form ARS | |
02/08/2024 4:10 PM | Attar Eyal C. (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 4:05 PM | Chakraborty Tirtha (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 4:06 PM | Jorgensen Nathan D. (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 4:08 PM | ANG ROBERT (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 6:38 PM | Attar Eyal C. (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 6:34 PM | Jorgensen Nathan D. (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 6:35 PM | ANG ROBERT (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 6:36 PM | Chakraborty Tirtha (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |